Monday, Aug 03, 2020 | Last Update : 11:58 PM IST

132nd Day Of Lockdown

Maharashtra44122827680915576 Tamil Nadu2632221964834132 Andhra Pradesh166586828861474 Delhi1384821233174004 Karnataka134819577252496 Uttar Pradesh97362533571730 West Bengal75516527301678 Telangana6766048609551 Gujarat63684466892482 Bihar5956736637322 Rajasthan4495531216706 Assam4290532385105 Haryana3629729690433 Odisha3491321955236 Madhya Pradesh3353523550886 Kerala259121446383 Jammu and Kashmir2141613127396 Punjab1785311466423 Jharkhand121884513115 Chhatisgarh9608699158 Uttarakhand7593443786 Goa6530466853 Tripura5248346323 Puducherry3806230952 Manipur283117377 Himachal Pradesh2654150813 Arunachal Pradesh19359693 Nagaland19356484 Chandigarh111769819 Meghalaya8742645 Sikkim6582891 Mizoram4702580
  India   All India  20 May 2020  Virus in India diverging from the one originated in Wuhan, scientists say

Virus in India diverging from the one originated in Wuhan, scientists say

THE ASIAN AGE. | BALU PULIPAKA
Published : May 20, 2020, 11:23 am IST
Updated : May 20, 2020, 11:23 am IST

Scientists caution that low testing rate minimal genome submissions are major bottlenecks in the assessment of the evolution of SARS-CoV-2

Electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. (AP)
 Electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. (AP)

Hyderabad: A group of Indian scientists who have been working on understanding changes happening to the Coronavirus that causes Covid-19 has found that some structures of the virus are undergoing changes that show that the virus, in India, is diverging from the Wuhan strain.

Scientists also cautioned that the overall low testing rate in the country and a smaller number of genome submissions are emerging as major bottlenecks in the assessment of the evolution of SARS-CoV-2 in India.

 

According to Dr Syed E Hasnain, vice-chancellor of Jamia Hamdard and a former head of the city-based Centre for DNA Fingerprinting and Diagnostics, the group studied approximately 4,000 SARS-CoV-2 sequences available in public databases, including strains sequenced in India.

“Other studies focused majorly on the genomic aspect of the virus. Our study evaluated both genomic as well as functional aspects of the virus in the Indian and global scenario. Large-scale analysis revealed significant changes in some proteins of the virus. We also focused on conserved proteins that can be targeted as potential diagnostic and intervention candidates,” Dr Hasnanin said.

 

The study by Jamia Hamdard, a deemed to be University in New Delhi, the United Kingdom-based BioInception Labs Pvt Ltd., an R&D company focused on drug discovery and diagnostics, and Hyderabad based Envirozyme Biotech Pvt Ltd. (India), an applied R&D biotech company, started looking at possible reasons why India, having the second largest population in the world, reported just 2 per cent cases and 0.9 per cent mortalities of the worldwide cases of Covid-19.

While global death average is 40 deaths per million, as on May 17, in India it was 2 per million. “We began investigating possible reasons for this,” Dr Hasnain said.

Dr Hasnain explained that open reading frames (ORF) are responsible for protein production in an organism. SARS-CoV-2 has 12 ORFs and based on the mutational analysis of these ORFs, they found that their data suggests crucial mutations in Indian isolates, which may affect infectivity of SARS-CoV-2 in the Indian population. The Indian samples of the virus revealed that they were closer to the virus variations in China, Kuwait, Spain, Norway and Canada, indicating that these strains travelled from these countries into India.He said their study indicated that delayed restrictions enforced by India could have resulted in the different strains of virus coming into India, particularly from European hotspot regions.

 

“More such studies are required to understand the pathogen’s outbreak dynamics, which will eventually lead to mitigation of the disease. The low sampling rate and a smaller number of genome submissions are major bottlenecks in assessing evolution of SARS-CoV-2 in India. We hope the government will work to increase the sampling rate as well as genomic submissions for further studies,” he said.

“A rapid and diverse sequencing of viral strains will help researchers find better diagnostics probes leading to higher sensitivity and specificity, improved drug efficacy and broad-spectrum Covid-19 vaccines,” Dr Hasnain said.

Tags: virus evolution, wuhan strain, coronaviruses, sars-cov-2, covid-19 testing
Location: India, Telangana, Hyderabad